Skip to content

How Food Choices Shape Memory, Cognition & Cravings | Dr. Scott Kanoski

Huberman Lab

Hosted by Andrew D. Huberman

2h 2m
Transcript

Original podcast

Where to listen

Summary

Written by a model from the transcript; not yet reviewed.

This episode explores how diet, food processing, and hormones shape memory, cognition, and cravings. The guest, Dr. Scott Kanowski, and the host, Andrew Huberman, examine the mechanisms of GLP-1 medications, the long-term impact of high-sugar and junk food diets on hippocampal-dependent memory, and the gut-brain axis involving the vagus nerve. They discuss preclinical findings on heat-treated foods and artificial sweeteners, the role of the microbiome in cognitive deficits, and how the brain processes interoceptive signals.

Listeners will gain a detailed neurobiological perspective on why modern diets affect mental performance, how gut signaling drives satiety and learning, and the complex science behind weight-loss drugs and artificial additives. The conversation offers valuable insights into the intersection of nutrition, metabolic health, and neurological function.

  • Consumption of high-sugar and high-fat diets during development can lead to persistent, long-term hippocampal-dependent memory impairments. 0:20
  • GLP-1 receptor agonists suppress appetite largely through peripheral vagus nerve signaling to the brainstem. 15:24
  • Specific gut bacteria changes caused by poor diet can directly transfer and induce memory deficits in experimental models. 1:29:33

Chapters

  1. 0:00
    Podcast Introduction and Host Overview

    The episode opens with the host welcoming listeners and introducing Dr. Scott Kanoski, setting the stage for a deep dive into food, memory, and cognition.

  2. 3:01
    What Are GLPs and How Do They Work?

    Dr. Kanoski explains the biology of glucagon-like peptide 1 (GLP‑1), its secretion, and its role in appetite suppression and glucose regulation.

  3. 5:12
    Side Effects and Limitations of GLP‑Based Drugs

    The discussion covers common side effects such as nausea, the challenge of long‑term efficacy, and the lack of data on microdosing practices.

  4. 7:48
    Memory, Food, and the Brain’s Reward Circuitry

    Dr. Kanoski describes how GLP‑1 receptors in the hippocampus and reward pathways may influence memory and food cravings beyond gut signals.

  5. 19:19
    Artificial Sweeteners and Appetite Regulation

    The conversation explores the controversial evidence on low‑calorie sweeteners, their impact on appetite, metabolism, and potential cognitive effects.

  6. 39:07
    Processed Foods, Maillard Reaction, and AGEs

    The hosts discuss how heat‑treated foods generate advanced glycation end products (AGEs), their potential neurocognitive impact, and the role of the microbiome.

  7. 45:39
    Linking Mid‑Life Diet to Late‑Life Dementia

    Dr. Kanoski reviews epidemiological and animal data connecting Western diets, metabolic dysfunction, and increased risk of Alzheimer’s‑like pathology.

  8. 50:54
    Future Directions: Gut–Brain Axis and Alzheimer’s

    The conversation concludes with speculation on how vagus nerve disruption and gut health may influence Alzheimer’s disease risk and the need for further research.

  9. 53:08
    Vagus Nerve Stimulation in Alzheimer Models

    Exploration of stomach‑sensing VNS devices and their potential to rescue memory deficits in transgenic rat models of Alzheimer’s disease.

  10. 54:25
    Gut–Brain Communication and Memory

    Discussion of how gut signals via the vagus nerve and hormones inform hippocampal function and influence memory and survival.

  11. 1:00:47
    Human Dietary Patterns and Hippocampal Memory

    Review of human studies linking habitual sugar and saturated fat intake to poorer performance on hippocampal‑dependent memory tasks.

  12. 1:01:21
    Challenges of Human Nutrition Research

    Examination of the limitations in accurately measuring human food intake and the implications for studying diet–memory relationships.

  13. 1:02:08
    Engineering Nutrient‑Rich Foods

    Debate over the feasibility and industry barriers to producing foods fortified with micronutrients and polyphenols.

  14. 1:10:00
    Exercise, Diet, and Memory Recovery

    The episode examines evidence that exercise can reverse diet‑induced memory deficits in animal models, highlighting the interplay between lifestyle factors and cognition.

  15. 1:13:11
    Future Directions in Gut–Brain Research

    Speculation on upcoming experiments, such as nutrient infusion without taste, and the broader potential for gut‑centric therapies in cognition.

Highlights

  • 3:31

    Natural versus Superphysiological GLP-1insight

    The guest explains that natural GLP-1 is an incretin hormone secreted from the intestines and brainstem to suppress hunger, whereas modern GLP-1 drugs elevate these levels a thousandfold.

  • 17:47

    Vagus Nerve Lesions Block GLP-1data

    Research shows that if you lesion the sensory vagus nerve connecting the GI tract to the brain, native GLP-1 is no longer effective at reducing food intake.

  • 22:59

    Artificial Sweetener Preclinical Studydata

    Rodents given daily doses of artificial sweeteners during development showed memory impairments and heightened insulin spikes as adults.

  • 27:06

    Manipulating Meal Memory in Humansstory

    Studies demonstrate that a person's subsequent hunger and eating behavior are heavily driven by their cognitive memory of how much food they believe they consumed.

  • 37:40

    Maillard Reaction and AGEsinsight

    Heat-treating healthy food induces the Maillard reaction, introducing advanced glycation end products that may negatively impact neurocognition and the microbiome.

  • 40:28

    Microbiome Rescue of Memorystrategy

    Researchers found that wiping out specific bacterial populations and enriching beneficial ones could rescue or reverse diet-induced memory deficits.

  • 1:18:50

    Hippocampal Acetylcholine Rampingdata

    Fiber photometry reveals that acetylcholine levels in the hippocampus ramp up dynamically during active eating and remain elevated postprandial.

Quotes

  • “The hippocampus is somewhat of a canary in the coal mine.”
    Unnamed speaker · 35:02
  • “In fact, the first application of GLP-1-based drugs was for diabetes treatment, not for obesity, but because they also suppress appetite and food intake, which leads to body weight loss.”
    Unnamed speaker · 4:37
  • “The peripheral GLP-1 and the central GLP-1 have very similar effects.”
    Unnamed speaker · 4:05
  • “They show these memory impairments that last even after you switch them to a healthy diet.”
    Unnamed speaker · 0:50
  • “We have a preprint, it's which is not a peer reviewed publication yet. It's sort of in, in the process of becoming that, hopefully someday.”
    Unnamed speaker · 36:50
  • “The gut is constantly updating, like, the body is getting what it needs. Therefore, if you're a neuron in the hippocampus, you can basically stay functional and alive.”
    Andrew D. Huberman · 58:35
  • “We have devices that are called Vagus nerve stimulation devices. And we can implant them. There's different kinds of VNS devices.”
    Unnamed speaker · 53:27
  • “The most extreme example of the plasticity of that system is with like a conditioned taste aversion, right?”
    Unnamed speaker · 1:49:02
  • “Oxytocin is released or created in the PVH in the hypothalamus, released into the circulation, but also there's projections from oxytocin producing neurons throughout the brain.”
    Unnamed speaker · 1:57:21
  • “If you genetically turn down the signal, the animals don't show that effect.”
    Unnamed speaker · 1:58:28
  • Our Place 10:36–11:51
  • Helix Sleep 11:33–13:24
  • LMNT 1:11:33–1:13:01
  • Function 1:37:22–1:39:00
  • Huberman Lab 2:00:47–2:01:49

About this episode

Dr. Scott Kanoski, PhD, is a Professor of Human and Evolutionary Biology and Neurobiology at the University of Southern California. We discuss how different foods impact memory and cognitive function as well as cravings. We also discuss how GLP-1 drugs work to control hunger in the brain and body, the role of the gut microbiome, and the effects of artificial and low calorie sweeteners on hunger and satiety. This episode highlights how nutrition impacts much brain health and learning capacity and how our memory impacts food choices too. Read the full episode show notes at hubermanlab.com. Thank you to our sponsors AG1: https://drinkag1.com/huberman Function: https://functionhealth.com/huberman Helix Sleep: https://helixsleep.com/huberman LMNT: https://drinklmnt.com/huberman Our Place: https://fromourplace.com/huberman Timestamps (00:00:00) Scott Kanoski (00:02:33) GLP-1, Natural GLP-1 Production; GLP-1 Drugs, Microdosing (00:07:06) GLP-1 Drugs & Benefits (00:10:36) Sponsor: Our Place & Helix Sleep (00:13:24) GLP-1 & Hunger Suppression, Vagus Nerve; Food Noise (00:18:39) Artificial Sweeteners & Appetite, Preclinical Studies (00:26:50) Memory & Meals; Stress; Eating & Individualization, Fasting (00:33:42) Memory Impairments, Western Diet, High Sugar, Processed Food (00:42:33) Sponsor: AG1 (00:43:46) Dementia, Alzheimer’s Disease & Western Diet; Exercise (00:49:40) Vagus Nerve, Hippocampus & Memory, Hormones (00:57:10) Sugar & Fat Consumption, Memory; Engineering Food for Quality (01:04:32) GLP-1s, Nutrient Deficiency, Weight Loss & Other Effects (01:11:33) Sponsor: LMNT (01:12:54) Vagus Nerve & Hippocampus, Eating & Acetylcholine (01:21:05) Hippocampus, Memory & Food; Interoceptive Awareness & Western Diet (01:27:21) Omega-3s; Microbiome & Processed Foods (01:34:00) Microbiome, Antibiotics, C. diff Infection (01:37:23) Sponsor: Function (01:39:01) Foods to Enhance Microbiome; Rising Obesity & Highly Processed Food (01:43:39) Dopamine & Food Choice, Change Food Cravings (01:49:50) Food Addiction, Highly Processed Foods; Political Lobbying (01:56:43) Oxytocin, Reduced Food Consumption, Social Eating (02:00:11) Zero-Cost Support, YouTube, Spotify & Apple Follow, Reviews & Feedback, Sponsors, Social Media, Neural Network Newsletter Learn more about your ad choices. Visit megaphone.fm/adchoices

Transcript

0:00
2:02:06

21,286 words · 2 speakers

Speaker names marked are inferred from speaking time and the show’s known hosts — they are not voice-verified.

Topics

  • GLP-1
  • Hippocampus
  • Vagus nerve
  • Maillard reaction
  • GLP drugs
  • Ozempic
  • Wegovy
  • Nucleus accumbens
  • American Heart Association
  • fiber photometry

Page updated · transcript and summary are machine-generated